PCSK9 and familial hypercholesterolemia: PCSK9 was recently identified as a potential therapeutic target to treat hypercholesterolemia, first in targeted patient populations of familial hypercholesterolemia and followed by cardiovascular diseases, in which recommended cholesterol levels were not met or cardiovascular risk remained high despite optimal drug therapy.14